Stock & Company Details
Achieve Life Sciences Inc. $ACHV
Price:
N/A
N/A
103M
$706M
52 Week High:
N/A
10 Day Average Volume:
N/A
-6.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ACHV technical indicators
Latest Achieve Life Sciences Inc. (ACHV) indicator readings as of 2026-10-29.
ACHV's 14-day RSI is 53.6, in neutral territory. At $7.19 it is trading 27.6% above its 200-day moving average of $5.64, and below its 50-day average of $7.48. Price sits in the middle of its Bollinger Bands ($6.27 to $7.49). ADX reads 18.6, indicating a range-bound market rather than a trend.
Overview
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.
Finance Bot
Ask your questions
Start by typing a question below.
